Updated September 9, 2026. The numbers are our own calculations on market data.
The model is in a buy. Hold — and sell if the price drops below the stop level.
The model is in a buy and the trend points up.
The check mark shows which one stands best on each point. We do not score share price or market capitalisation against each other — those numbers say nothing about which stock is better.
| Key figure | Pfizer | Merck |
|---|---|---|
| Our verdict today Buy / Hold / Sell | Hold | Buy ✓ |
| TD-Rank Overall placing among all stocks | 67/100 ✓ | 44/100 |
| Value Cheap for what you get? | 49/100 ✓ | 14/100 |
| Quality Healthy business and balance sheet | 72/100 ✓ | 29/100 |
| Momentum Does the price have a tailwind? | 80/100 | 91/100 ✓ |
| Distance to price target Average analyst price target | +2.7% ✓ | +0.4% |
| Distance to the stop level How close the price is to a sell | +1.5% | +2.7% |
| Position in the 52-week range 0% = 52-week low, 100% = 52-week high | 81% | 90% |
| Dividend Expected dividend as a percentage of the price | 5.97% ✓ | 2.18% |
| Return on equity (ROE) How well the company earns on the owners' money | 5.0% | 7.0% ✓ |
| Forward P/E Lower = you pay less per dollar of earnings | 9.9 ✓ | 15.7 |
Enter the two tickers exactly as they appear on their page here — for example aapl.us and
msft.us. You will find the ticker in the address of a stock page:
wallstreetbuys.com/stocks/aapl.us. US stocks end in .us here.
Merck stands strongest today. Measured on our verdict, the TD-Rank and the distance to the analyst price target, Merck is the one of the two we would look at more closely. That does not make Pfizer a bad stock — below you can see where it is stronger. Pfizer has a TD-Rank of 67/100 and the verdict "Hold". Merck has a TD-Rank of 44/100 and the verdict "Buy". The full comparison is at https://wallstreetbuys.com/compare/pfizer-vs-merck.
It depends on what you are looking for, but measured on our model: Merck stands strongest today. Measured on our verdict, the TD-Rank and the distance to the analyst price target, Merck is the one of the two we would look at more closely. That does not make Pfizer a bad stock — below you can see where it is stronger. We never compare the share prices directly — a price on its own tells you nothing. We compare the verdict, the TD-Rank, value/quality/momentum and the distance to the analyst price target.
Merck is the one our model points at today. Remember that a buy signal is not a guarantee — always use a stop level so you get out in time if it turns.
This page does it for free: https://wallstreetbuys.com/compare. WallStreetBuys gives a daily buy/hold/sell verdict plus a buy level and a stop level for Pfizer, Merck and the rest of the US market. If you want to draw technical analysis yourself, TradingView is stronger; if you only need news and prices, Yahoo Finance and Finviz will do.
Read also: all US stocks · buy signals · best dividend stocks · best stocks this year
This is information, not individual investment advice. The numbers are our own calculations on market data and may contain errors. Past results are no guarantee of the future. You decide for yourself — and remember to spread your risk.